News & Articles

Presenting a simple solution to challenges in nucleic acid extraction from FFPE samples, for use in next generation sequencing workflows.

ClearLLab products improve laboratory workflow by reducing manual preparation and routine validation

The next BIG prize drawing is only days away - simply write a laboratory product review today for your chance to win a $400 Amazon voucher or an iPad

Study will evaluate Owlstone Medical’s ‘breathalyzer for disease’ which aims identify breath biomarkers for early detection and diagnosis of numerous cancers

Chemical signatures from gut bacteria that show up in urine can be used to predict how the body will respond to a 'junk' diet.

New Panther Fusion module expands molecular testing capabilities, increases productivity and flexiblity for the laboratory

Discover the world’s only fully automated, GMP-compliant, CAR T cell manufacturing system

Experts from across the globe expected to descend on German capital for two-day workshop series, September 7-8

Horizon’s reference standards supported assay development and subsequent clinical trial

Find out how this busy laboratory in Italy has adapted to meet increased demand for clinical mass spectrometry testing

The 69th AACC annual scientific meeting and clinical lab expo will be taking place in San Diego between the 31st July- 3rd August 2017.

Sphere enhances connectivity functionality of Proxima acute respiratory and metabolic monitoring device in critical care settings

EKF Quo-Test HbA1c analyzer successfully evaluated at Swansea University Diabetes Research Unit

Assay now cleared for throat and rectal specimens for use on the panther system

By Guest Editor Jung Doh, Senior Applications Scientist, Beckman Coulter Life Sciences.

Customized multiplex xMAP assays enable the development of efficient, cost-effective diagnostic tests for cancer and infectious diseases

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 26

PD-L1 IHC 28-8 pharmDx will give more insight to which patients with urothelial cancer are most likely to benefit from Opdivo (nivolumab)